Literature DB >> 11838647

Surgical pathology of carcinoid heart disease: a study of 139 valves from 75 patients spanning 20 years.

Daniel V Simula1, William D Edwards, Henry D Tazelaar, Heidi M Connolly, Hartzell V Schaff.   

Abstract

OBJECTIVE: To quantitate the pathologic features of carcinoid plaques in a relatively large number of surgical specimens from a single institution. PATIENTS AND METHODS: Medical records, operative reports, and surgical specimens were reviewed from all patients with carcinoid heart disease who underwent cardiac valvular surgery at Mayo Clinic, Rochester, Minn, between 1980 and 2000.
RESULTS: The study group included 75 patients (45 men, 30 women) who ranged in age from 26 to 78 years (mean, 59 years). From these 75 patients, 139 valves had been excised surgically (73 tricuspid, 55 pulmonary, 6 mitral, 5 aortic). Pure regurgitation was the most common dysfunctional state of the tricuspid valve (80% [60/75]), mitral valve (97% [32/33]), and aortic valve (96% [23/24]). The pulmonary valve was more often both stenotic and insufficient (52% [37/71]) than purely regurgitant (30% [21/71]). In all cases, valve dysfunction was attributed to the presence of carcinoid plaques, which caused both thickening and retraction. Thickening was the result of both cellular proliferation and deposition of extracellular matrix. Proliferation of myofibroblasts was observed in all plaques and was mild in 49% (68/139) and moderate or severe in 51% (71/139). Extracellular matrix included collagen (in 99% of the 139 valves), myxoid ground substance (98% [136/139]), and elastin (20% [28/139]). Carcinoid plaques were also involved by neovascularization (94% [131/139]), chronic inflammation (94% [131/139]), and mast cell infiltration (64% [89/139]). Severe thickening was attributable primarily to collagen deposition in tricuspid valves and to myofibroblast proliferation and myxoid matrix in pulmonary valves.
CONCLUSIONS: Among patients undergoing valvular surgery for carcinoid heart disease, tricuspid and pulmonary valves represented 92% of the excised valves (128/ 139). Although numerous cellular and extracellular features were common to the carcinoid plaques, variability in their relative expression produced appreciable differences in the histologic appearance among the plaques.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11838647     DOI: 10.4065/77.2.139

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  15 in total

1.  Ovarian tumor-associated carcinoid heart disease presenting as severe tricuspid regurgitation.

Authors:  Hong-Won Shin; Hyungseop Kim; Hyuck-Jun Yoon; Hyoung-Seob Park; Yun-Kyeong Cho; Chang-Wook Nam; Seung-Ho Hur; Yoon-Nyun Kim; Kwon-Bae Kim
Journal:  J Cardiovasc Ultrasound       Date:  2011-03-31

2.  Cardiac surgery for carcinoid heart disease.

Authors:  Hiroaki Takahashi; Yutaka Okita
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-12-16

3.  Carcinoid heart disease: correlation of echocardiographic and histopathological findings.

Authors:  Lachlan Fraser Miles; Trishe Leong; Peter McCall; Laurence Weinberg
Journal:  BMJ Case Rep       Date:  2014-11-24

Review 4.  Ileal neuroendocrine tumors and heart: not only valvular consequences.

Authors:  Jan Calissendorff; Eva Maret; Anders Sundin; Henrik Falhammar
Journal:  Endocrine       Date:  2014-10-16       Impact factor: 3.633

Review 5.  Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.

Authors:  Mark A Oyama; Chad Elliott; Kerry A Loughran; Alexander P Kossar; Estibaliz Castillero; Robert J Levy; Giovanni Ferrari
Journal:  Cardiovasc Pathol       Date:  2020-01-07       Impact factor: 2.185

Review 6.  Carcinoid-syndrome: recent advances, current status and controversies.

Authors:  Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-02       Impact factor: 3.243

7.  Carcinoid valve disease.

Authors:  J Wells Askew; Heidi M Connolly
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

8.  Serotonin produces monoamine oxidase-dependent oxidative stress in human heart valves.

Authors:  Ricardo A Peña-Silva; Jordan D Miller; Yi Chu; Donald D Heistad
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-07       Impact factor: 4.733

Review 9.  Cabergoline use and risk of fibrosis and insufficiency of cardiac valves. Meta-analysis of observational studies.

Authors:  R De Vecchis; C Esposito; C Ariano
Journal:  Herz       Date:  2013-06-08       Impact factor: 1.443

Review 10.  Carcinoid heart disease.

Authors:  Heidi M Connolly; Patricia A Pellikka
Journal:  Curr Cardiol Rep       Date:  2006-03       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.